AKTIS ONCOLOGY TO PARTICIPATE IN 2023 GUGGENHEIM HEALTHCARE TALKS: RADIOPHARMACEUTICALS DAY

Autor: PR Newswire
Zdroj: PR Newswire US. 05/12/2023.
Abstrakt: CAMBRIDGE, Mass., May 12, 2023 /PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced Matthew Roden, PhD, President and Chief Executive Officer, and Shulamit Ron-Bigger, PhD, Chief Operating Officer, will participate in the 2023 Guggenheim Healthcare Talks: Radiopharmaceuticals Day, held on May 15 in New York City. Alongside the leading thinkers in cancer research, Aktis senior leadership will provide a company overview in a fireside chat at 2:10 pm ET, as well as participate in one-on-one investor meetings. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje